DOD
Search
Discussions
Biomedical Jobmarket
News
DOD Alert
Edit DOD
 
ACCOUNT
Login
Register
Forgotten Password?
 
 
Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors.
 
Diabetes OD > Disease Management > T2DM > Metabolic Control > Anti-Hyperglycemic and Anti-Apoptotic Agents > Incretin Hormones > GLP-1 > Effectivity of GLP-1 in Therapy > Degradation by Dipeptidyl Peptidase IV > Dipeptidyl-Peptidase IV Inhibitors > Journal Article

(Journal Article): Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors.
 
Holst JJ, Deacon CF (Department of Medical Physiology, University of Copenhagen, The Panum Institute, Blegdamsvej 3, 2200 Copenhagen N, Denmark., holst@mfi.ku.dk )
 
IN: Diabetologia 2005; 48(4):612-615
Impact Factor(s) of Diabetologia: 5.583 (2004), 5.689 (2003), 5.136 (2002), 6.299 (2001)

Fulltext:    HTML  PDF

ABSTRACT: n.a.

TYPE OF PUBLICATION: Comment

Articles citing this article:



 
Respond on this Journal Article!
Hint: Your Response should directly apply to Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors.. Please check, if this context applies best to your contribution. Otherwise click HERE to change to the appropriate subject area. The actual subject area is Dipeptidyl-Peptidase IV Inhibitors.